TrialPloS one2022

Efficacy of colchicine in patients with moderate COVID-19: A double-blinded, randomized, placebo-controlled trial.

Motlabur Rahman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.